| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | +17.7% |
| Cost of Revenue | $3.3M | +34.2% |
| Gross Profit | $7.9M | +12.0% |
| R&D Expense | $243K | +16.8% |
| SG&A Expense | $6.2M | +14.9% |
| Operating Income | $1.7M | +2.5% |
| Pre-tax Income | $2.1M | +4.9% |
| Income Tax | $533K | +34.1% |
| Net Income | $1.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -35.3% |
| Short-term Investments | $4.6M | +207.9% |
| Accounts Receivable | $2.3M | +11.1% |
| Inventory | $1.9M | -33.3% |
| Current Assets | $11.8M | +13.3% |
| Total Assets | $13.5M | +15.2% |
| Current Liabilities | $1.2M | -14.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.0M | +411.0% |
| Capital Expenditures | $129K | +227.4% |
| Investing Cash Flow | -$3.1M | -99.9% |
| Financing Cash Flow | -$139K | -2.3% |
| Free Cash Flow | $1.9M | +431.3% |
| -2.3% |
| EPS (Basic) | $0.34 | -2.9% |
| EPS (Diluted) | $0.34 | -2.9% |
| Total Liabilities |
| $2.1M |
| +11.9% |
| Stockholders' Equity | $11.5M | +15.8% |